IBL HealthCare Limited (PSX:IBLHL)
51.13
+4.65 (10.00%)
At close: Jun 5, 2026
IBL HealthCare Ratios and Metrics
Market cap in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 4, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 5,038 | 5,363 | 2,648 | 2,324 | 3,374 | 6,011 | |
Market Cap Growth | 34.52% | 102.52% | 13.95% | -31.13% | -43.86% | 43.49% |
Enterprise Value | 5,285 | 5,723 | 2,772 | 2,576 | 3,570 | 6,294 |
Last Close Price | 51.13 | 54.43 | 26.88 | 23.59 | 33.54 | 59.16 |
PE Ratio | 20.90 | 25.74 | 350.52 | 7.52 | 11.14 | 20.00 |
PS Ratio | 1.12 | 1.24 | 0.74 | 0.58 | 0.92 | 2.00 |
PB Ratio | 2.02 | 2.31 | 1.25 | 1.10 | 1.81 | 3.72 |
P/TBV Ratio | 2.02 | 2.31 | 1.25 | 1.11 | 1.82 | 3.75 |
P/FCF Ratio | 258.18 | - | 4.68 | 95.49 | 60.74 | 92.35 |
P/OCF Ratio | 200.77 | - | 4.66 | 85.54 | 59.36 | 85.90 |
EV/Sales Ratio | 1.18 | 1.32 | 0.77 | 0.64 | 0.98 | 2.10 |
EV/EBITDA Ratio | 9.92 | 12.78 | 17.72 | 4.20 | 6.20 | 15.29 |
EV/EBIT Ratio | 10.13 | 12.87 | 18.08 | 4.23 | 6.26 | 15.47 |
EV/FCF Ratio | 270.88 | - | 4.89 | 105.87 | 64.26 | 96.70 |
Debt / Equity Ratio | 0.18 | 0.07 | 0.01 | 0.14 | 0.14 | 0.16 |
Debt / EBITDA Ratio | 0.86 | 0.35 | 0.14 | 0.48 | 0.46 | 0.62 |
Debt / FCF Ratio | 23.40 | - | 0.04 | 12.23 | 4.81 | 3.97 |
Net Debt / Equity Ratio | 0.14 | -0.02 | -0.17 | 0.10 | 0.09 | 0.10 |
Net Debt / EBITDA Ratio | 0.65 | -0.11 | -2.26 | 0.33 | 0.28 | 0.41 |
Net Debt / FCF Ratio | 17.66 | 0.18 | -0.62 | 8.29 | 2.94 | 2.57 |
Asset Turnover | 1.12 | 1.18 | 1.05 | 1.24 | 1.36 | 1.28 |
Inventory Turnover | 2.60 | 2.65 | 2.53 | 2.49 | 2.85 | 2.91 |
Quick Ratio | 1.34 | 1.19 | 1.44 | 1.03 | 1.15 | 1.20 |
Current Ratio | 2.01 | 2.02 | 2.24 | 2.05 | 2.20 | 2.27 |
Return on Equity (ROE) | 10.14% | 9.39% | 0.36% | 15.56% | 17.42% | 19.79% |
Return on Assets (ROA) | 8.15% | 7.58% | 2.79% | 11.76% | 13.27% | 10.82% |
Return on Invested Capital (ROIC) | 9.28% | 12.18% | 0.52% | 18.94% | 18.79% | 17.77% |
Return on Capital Employed (ROCE) | 20.80% | 19.00% | 7.30% | 28.90% | 30.50% | 24.90% |
Earnings Yield | 4.77% | 3.89% | 0.29% | 13.30% | 8.97% | 5.00% |
FCF Yield | 0.39% | -5.20% | 21.39% | 1.05% | 1.65% | 1.08% |
Dividend Yield | - | - | - | - | 1.96% | 0.93% |
Payout Ratio | 0.01% | 0.08% | 0.56% | 20.11% | 17.05% | 34.42% |
Buyback Yield / Dilution | 0.36% | - | - | 0.00% | -0.00% | 0.00% |
Total Shareholder Return | 0.36% | - | - | - | 1.96% | 0.93% |